Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Niagen Bioscience (NAGE) Prepaid Assets (2016 - 2025)

Niagen Bioscience (NAGE) has disclosed Prepaid Assets for 13 consecutive years, with $1.3 million as the latest value for Q4 2025.

  • Quarterly Prepaid Assets fell 47.14% to $1.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.3 million through Dec 2025, down 47.14% year-over-year, with the annual reading at $1.3 million for FY2025, 47.14% down from the prior year.
  • Prepaid Assets for Q4 2025 was $1.3 million at Niagen Bioscience, down from $2.0 million in the prior quarter.
  • The five-year high for Prepaid Assets was $4.3 million in Q3 2022, with the low at $972000.0 in Q2 2021.
  • Average Prepaid Assets over 5 years is $2.1 million, with a median of $2.1 million recorded in 2024.
  • The sharpest move saw Prepaid Assets surged 141.71% in 2022, then tumbled 48.74% in 2023.
  • Over 5 years, Prepaid Assets stood at $1.9 million in 2021, then soared by 59.6% to $3.0 million in 2022, then decreased by 17.43% to $2.4 million in 2023, then grew by 1.31% to $2.5 million in 2024, then crashed by 47.14% to $1.3 million in 2025.
  • According to Business Quant data, Prepaid Assets over the past three periods came in at $1.3 million, $2.0 million, and $2.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.